699 related articles for article (PubMed ID: 1673880)
1. Pharmacokinetic and pharmacodynamic properties of histamine H2-receptor antagonists. Relationship between intrinsic potency and effective plasma concentrations.
Lin JH
Clin Pharmacokinet; 1991 Mar; 20(3):218-36. PubMed ID: 1673880
[TBL] [Abstract][Full Text] [Related]
2. A comparison of some of the pharmacological properties of etintidine, a new histamine H2-receptor antagonist, with those of cimetidine, ranitidine and tiotidine.
Cavanagh RL; Usakewicz JJ; Buyniski JP
J Pharmacol Exp Ther; 1983 Jan; 224(1):171-9. PubMed ID: 6129316
[TBL] [Abstract][Full Text] [Related]
3. Effects of H2-receptor antagonists on 3H-cimetidine binding and histamine-stimulation of cellular cAMP in isolated guinea pig gastric glands.
Tanaka A; Nishihara S; Misawa T; Ibayashi H
Jpn J Pharmacol; 1987 Sep; 45(1):97-105. PubMed ID: 2890783
[TBL] [Abstract][Full Text] [Related]
4. Mechanism of action of H2-antagonists on histamine- or dimaprit-stimulated H2-receptors of spontaneously beating guinea-pig atrium.
Krielaart MJ; Veenstra DM; van Buuren KJ
Agents Actions; 1990 Aug; 31(1-2):23-35. PubMed ID: 1704683
[TBL] [Abstract][Full Text] [Related]
5. Newer H2-receptor antagonists. Clinical pharmacokinetics and drug interaction potential.
Krishna DR; Klotz U
Clin Pharmacokinet; 1988 Oct; 15(4):205-15. PubMed ID: 2903807
[TBL] [Abstract][Full Text] [Related]
6. Clinical pharmacokinetics of famotidine.
Echizen H; Ishizaki T
Clin Pharmacokinet; 1991 Sep; 21(3):178-94. PubMed ID: 1764869
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetic optimisation in the treatment of gastro-oesophageal reflux disease.
Hatlebakk JG; Berstad A
Clin Pharmacokinet; 1996 Nov; 31(5):386-406. PubMed ID: 9118586
[TBL] [Abstract][Full Text] [Related]
8. Effects of H2-receptor antagonists on gastric alcohol dehydrogenase activity.
Caballería J; Baraona E; Deulofeu R; Hernández-Muñoz R; Rodés J; Lieber CS
Dig Dis Sci; 1991 Dec; 36(12):1673-9. PubMed ID: 1684149
[TBL] [Abstract][Full Text] [Related]
9. Neurotoxic convulsions induced by histamine H2 receptor antagonists in mice.
Shimokawa M; Yamamoto K; Kawakami J; Sawada Y; Iga T
Toxicol Appl Pharmacol; 1996 Feb; 136(2):317-23. PubMed ID: 8619239
[TBL] [Abstract][Full Text] [Related]
10. The pharmacology of histamine H2-receptor antagonists.
Mills JG; Wood JR
Methods Find Exp Clin Pharmacol; 1989; 11 Suppl 1():87-95. PubMed ID: 2566729
[TBL] [Abstract][Full Text] [Related]
11. H2-antagonists and alcohol. Do they interact?
Gugler R
Drug Saf; 1994 Apr; 10(4):271-80. PubMed ID: 7912509
[TBL] [Abstract][Full Text] [Related]
12. The antisecretory profile of action of the H2-receptor antagonists, famotidine, loxtidine, ranitidine and L-643,441 on the rat isolated gastric mucosa.
Reeves JJ; Stables R
Agents Actions; 1987 Feb; 20(1-2):22-8. PubMed ID: 2883848
[TBL] [Abstract][Full Text] [Related]
13. Extremely early onset of ranitidine action on human histamine H2 receptors expressed in HEK293 cells.
Fukushima Y; Ishikawa T; Saitoh T; Tateishi K; Ogihara T; Fujishiro M; Shojima N; Honda M; Kushiyama A; Anai M; Sakoda H; Ono H; Onishi Y; Otsuka H; Katagiri H; Nagai R; Omata M; Asano T
Digestion; 2003; 68(2-3):145-52. PubMed ID: 14671421
[TBL] [Abstract][Full Text] [Related]
14. Pharmacology of H2-receptor antagonists: an overview.
Schunack W
J Int Med Res; 1989; 17 Suppl 1():9A-16A. PubMed ID: 2566544
[TBL] [Abstract][Full Text] [Related]
15. Pharmacodynamics and pharmacokinetics of parenteral histamine (H2)-receptor antagonists.
Ostro MJ
Am J Med; 1987 Dec; 83(6A):15-22. PubMed ID: 2892405
[TBL] [Abstract][Full Text] [Related]
16. [Effects of various histamine H2-receptor antagonists on gastrointestinal motility and gastric emptying].
Ohira Y; Hanyu N; Aoki T; Hashimoto Y; Iikura M; Fukuda S
J Smooth Muscle Res; 1993 Aug; 29(4):131-42. PubMed ID: 7907895
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological control of the human gastric histamine H2 receptor by famotidine: comparison with H1, H2 and H3 receptor agonists and antagonists.
Gespach C; Fagot D; Emami S
Eur J Clin Invest; 1989 Feb; 19(1):1-10. PubMed ID: 2567239
[TBL] [Abstract][Full Text] [Related]
18. [Gastric acid secretion and histamine H2 receptor antagonists].
Gespach C; Emami S; Di Gioia Y; Chastre E
Gastroenterol Clin Biol; 1990; 14(12):982-94. PubMed ID: 1981198
[No Abstract] [Full Text] [Related]
19. Inhibitory effect of etintidine (BL-5641), a new type of H2 receptor antagonist, on binding of [3H]-cimetidine to plasma membrane and histamine-stimulated cellular cAMP production in isolated guinea pig gastric glands.
Nishihara S; Tanaka A; Tazoe A; Yoshida K; Misawa T; Ibayashi H
Gastroenterol Jpn; 1986 Apr; 21(2):106-11. PubMed ID: 2872137
[TBL] [Abstract][Full Text] [Related]
20. Control of gastric acid secretion. Histamine H2-receptor antagonists and H+K(+)-ATPase inhibitors.
Shamburek RD; Schubert ML
Gastroenterol Clin North Am; 1992 Sep; 21(3):527-50. PubMed ID: 1355465
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
